News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|March 1, 2006

Upcoming for ADHD meds: Black box warning?

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Severity Scoring and First-Line Topical Therapy for Pediatric AD

ByLisa Swanson, MD, Ada West Dermatology

August 1st 2026

How to Recognize Early Pediatric AD and Rule Out Cradle Cap

ByLisa Swanson, MD, Ada West Dermatology

August 1st 2026

Younger children face higher risk after water bead ingestion

Younger children face higher risk after water bead ingestion

ByMorgan Ebert, Executive Editor

July 31st 2026

Parenting role models shape mothers' COVID-19 vaccination intent | Image Credit: © Studio Romantic - stock.adobe.com

Parenting role models shape mothers' COVID-19 vaccination intent

ByContemporary Pediatrics Staff

July 31st 2026

CTx-1301 improves pediatric ADHD symptoms in phase 3 trial | Image Credit: © Tiara - stock.adobe.com.

CTx-1301 improves pediatric ADHD symptoms in phase 3 trial

ByContemporary Pediatrics Staff

July 30th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Jeff Temple, PhD, urges balanced screen use as families prepare for back-to-school routines

Family history alone may not prompt type 1 diabetes screening, survey finds

Ensitrelvir now available in US for COVID-19 postexposure prophylaxis

Severity Scoring and First-Line Topical Therapy for Pediatric AD

FDA clears pediatric Patient State Index for Masimo SedLine sedation monitoring